MedTrace Logo

A Family-Based Diabetes Intervention for Hispanic Adults in an Emerging Community

NCT02114814 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 186

Last updated 2022-05-24

Study results available
· View outcomes & findings →

Summary

The aim of this study was to compare the efficacy of an intervention and an attention control group in producing changes in diabetes self-management, glycemic control (HbA1c) and health related quality of life in Hispanics with type 2 diabetes.

Hypothesis: The experimental group who receive an 8 week intervention program would show significantly greater improvements than an attention control group at 1 and 6 months after the intervention in: behavioral influences of diabetes knowledge, diabetes self-efficacy, and family support, outcomes of self-reported management of diabetes (physical activity, diet, medications, and glucose monitoring), HbA1c levels, and psychological outcomes of health-related quality of life.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

BEHAVIORAL

Diabetes self-management program for Hispanics and their families

The intervention group received an 8-weekly culturally tailored diabetes self-management and family support education program delivered in Spanish

BEHAVIORAL

General health educational program for Hispanics and their families

The attention control group received 8-weekly education program on general health information

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • University of North Carolina, Greensboro

    collaborator OTHER

  • Ohio State University

    lead OTHER

Principal Investigators

  • Jie Hu, PhD · Ohio State University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2015-05-31
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02114814 on ClinicalTrials.gov